Coenzyme Q10 (CoQ10)
CoQ10 is not the longevity supplement its marketing implies. In the general population, people who take it are no less likely to die than people who don't, and in people with obesity there is a borderline hint of harm; the real evidence is narrow — heart failure, older people low in selenium, migraine, and one rare inherited disease where it is a genuine treatment.
Most healthy adults have no good reason to take it. If you have one of the narrow reasons and you and your doctor decide to take it, use plain ubiquinone with a meal that contains fat: the heart-failure and migraine trials used 300 mg a day, the inherited deficiency is treated at high doses by a specialist, and for other uses 100–200 mg a day is enough. If you take warfarin or are having cancer treatment, talk to your prescriber or oncologist before starting.
What CoQ10 does, and why people take it
Coenzyme Q10 is a fat-soluble molecule the body makes itself and also gets from food, and it sits in the membranes of every cell. It does two jobs. In mitochondria, the cell's power plants, it carries electrons in the chain of reactions that produces adenosine triphosphate (ATP), the cell's main energy currency.[1] And in its reduced form, ubiquinol, it works as an antioxidant in fatty membranes; the oxidized form is ubiquinone.[2]
Two facts make it interesting for aging. In one autopsy study, CoQ10 levels in most human organs, the heart among them, peaked around age 20 and fell steadily after that.[3] And statins lower it: the pathway they block to cut cholesterol is the same one the body uses to build CoQ10, so statin therapy reliably lowers blood levels.[4] That is the entire mechanistic case for supplementing, and the trials show mechanism is not destiny: who takes it decides whether it helps, does nothing, or possibly harms.
Where it probably helps: heart failure and older people low in selenium
The strongest signals come from two randomized trials, both in people likely to be short of CoQ10, both backed by CoQ10 makers, and neither repeated.
KiSel-10 gave 443 community-dwelling Swedes aged 70–88 either 200 mg a day of CoQ10 plus 200 µg a day of selenium yeast, or placebo, for four years. Over about five years of follow-up, cardiovascular deaths were roughly halved: 5.9% against 12.6%.[5] The gap was still there at twelve years (28.1% against 38.7%).[6] The cohort turned out to have low average selenium, though selenium status was not an entry criterion, and the result cannot be separated from the selenium. Selenium has its own narrow uses and a real upper limit (see Selenium), so don't add it on your own. The authors call it hypothesis-generating, given the modest size and single centre.
Q-SYMBIO gave 420 people with moderate-to-severe chronic heart failure 300 mg a day on top of standard treatment. Its short-term goals at 16 weeks showed no difference, but over two years major cardiovascular events roughly halved (15% against 26%), and deaths, a secondary result, were about halved too.[7] No larger trial has since confirmed it.
The pooled evidence is thinner than it looks. A 2024 meta-analysis of 33 trials in heart failure found deaths about a third lower, but most of its trials were small and of low quality, so its precision overstates the certainty.[8] The 2021 Cochrane review concluded CoQ10 "probably reduces" deaths and hospital admissions for heart failure, but its mortality estimate rests on Q-SYMBIO alone, and its authors found no convincing evidence to support or refute CoQ10 for heart failure.[9] Most of this evidence comes from hearts that pump poorly (reduced ejection fraction); for the stiff-heart type (preserved ejection fraction), three small, short trials are too few to say.[10] The current US heart-failure guideline (2022) does not recommend supplements in reduced-ejection-fraction heart failure except to correct a specific deficiency.[11]
So: in heart failure with reduced ejection fraction, CoQ10 is at most an add-on to discuss with a cardiologist, never a replacement for prescribed drugs.
Where it doesn't: the general population
In broad populations the picture inverts. A study that pooled United States National Health and Nutrition Examination Survey (NHANES) data followed adults for about 10 years on average; only a few percent reported taking CoQ10. Use was not linked to living longer: the hazard ratio for death from any cause was 1.00, meaning no difference. In a subgroup analysis, users with obesity had about 45% higher mortality (hazard ratio 1.45, 95% confidence interval 1.01–2.08). The confidence interval is the range where the true effect most plausibly lies, and this one only just stays above 1.0, so it is a borderline, exploratory finding from an observational study. It may reflect who chooses to take supplements rather than harm from CoQ10.[12]
A German cohort of 1,333 adults adds a related signal: people with more of their blood CoQ10 in the oxidized form were more likely to die over about 13 years. That study measured blood levels, not supplement use.[13] One untested idea links the two: CoQ10 may help only if the body can keep it in its reduced form, which heavy oxidative stress, as in obesity, may prevent. The groundwork is thin and mostly from animal studies.[14] Nothing shows that more CoQ10, or a different form, helps people with metabolic problems, so be skeptical of it as a standalone fix there.
The one real treatment: an inherited deficiency
In primary CoQ10 deficiency, a group of rare inherited disorders, the body cannot build CoQ10 at all. Here early, high-dose oral CoQ10 can halt or partly reverse the disease, most notably a steroid-resistant kidney disease and some neurological forms.[15] The response depends on the gene, is weakest when the brain is affected, and needs treatment to start early.[16] It is the cleanest example of the pattern: CoQ10 works where a true deficit exists. The lower levels that come with aging, statins or chronic illness are a different thing, and there the benefit is at best marginal.
Statins and muscle aches: weaker than it sounds
Because statins lower CoQ10, it is widely tried for statin muscle aches and weakness, and the evidence is contested. Randomized trials show statins lower blood CoQ10 by roughly 16–54%,[17] but whether they lower it inside muscle is not clear.[18] In one small placebo-controlled trial with muscle biopsies, 400 mg a day for eight weeks raised neither muscle CoQ10 nor muscle mitochondrial function, and did not ease muscle pain.[19] The newest pooled analysis of seven small trials found a small drop in pain scores, but the trials carried a high risk of bias, and earlier pooled analyses disagreed: one found a benefit and three found none.[20]
The bigger caveat is the placebo effect. In the SAMSON trial, 60 people who had quit statins over side effects rotated through months of statin, placebo and no tablets; placebo months produced about 90% of the extra symptoms that statin months did.[21] So any "it worked for me" response to CoQ10 is hard to pin on the molecule. It is cheap and safe enough to try, but it is no substitute for the structured approach in Lipid management; six months after SAMSON, half its participants were taking a statin again.
Smaller effects: migraine, blood sugar and the rest
Migraine prevention is the best-supported of the smaller uses. In the anchor trial of 42 patients, 300 mg a day roughly tripled the share whose attacks halved (about 48% against 14% on placebo).[22] A 2026 pooled analysis estimated about two fewer attacks a month than placebo, with no clear effect on how long or how severe attacks were.[23] A 2012 US neurology guideline rated it "possibly effective", its lowest positive grade, but that guideline was retired in 2015 over a different remedy.[24] The trials are small.
Blood sugar: small, and dependent on how you analyse it. Pooling 40 short trials, CoQ10 slightly lowered fasting glucose, insulin and insulin resistance, with a borderline fall in long-term blood sugar (HbA1c) of about 0.1 percentage point, largest in people with diabetes.[25] A 2026 umbrella review found only the fasting-glucose effect held up under both of its methods.[26] This is a repletion-type effect, not a diabetes treatment.
Blood pressure: essentially no effect. The Cochrane review found a systolic change of about −3.7 mm Hg that was not significant once a high-risk-of-bias trial was left out.[27] Older claims of a ~16 mm Hg drop rested on open-label and biased trials.
Fertility: preliminary. In women with reduced ovarian reserve having in-vitro fertilisation (IVF), pooled trials link CoQ10 pretreatment to higher clinical pregnancy rates, but the trials were poorly reported and live birth is unproven.[28] In men, trials show better sperm motility; effects on pregnancy are unproven.[29]
Exercise: not a performance aid. Pooled small trials found no change in maximal oxygen uptake, a slight fall in an oxidative-damage marker, and a fall in a muscle-damage marker only in short, high-dose courses, all at low to very low certainty.[30] Resistance training fundamentals matter far more.
Where it fails: the brain, the skin and "longevity stacks"
The brain. Animal results are striking; human trials have mostly disappointed. The definitive Parkinson's trial randomized 600 people with early disease to 1,200 or 2,400 mg a day or placebo and was stopped for futility, with the active groups trending slightly worse.[31] A Huntington's-disease trial of 2,400 mg a day for up to five years was likewise halted.[32] A 2025 review found no consistent cognitive benefit and no basis for using it in dementia.[33] The blood–brain barrier blocks most CoQ10 from reaching the brain. One exception needs confirmation: in multiple system atrophy, a rare disease linked to a faulty CoQ10-building gene, 1,500 mg a day of ubiquinol slightly slowed the worsening of movement problems in a phase 2 trial of 139 patients.[34]
Skin and photoaging. The wrinkle evidence is for creams, not pills, and comes from two small, unpublished studies run by a skincare maker.[35] Sun protection is the lever that matters.
"Longevity stacks". Combinations sold to healthy adults — CoQ10 with nicotinamide mononucleotide (NMN), resveratrol and the like — rest on animal and mechanistic data, not human outcomes. See Geroprotectors.
Which form to buy
Plain ubiquinone is a sound default. Whether ubiquinol absorbs better depends heavily on the formulation, according to a review by authors working for a ubiquinone maker,[36] and in a 2026 head-to-head trial in 150 healthy adults its edge in blood levels was small and not statistically significant.[37] Both trials that moved a hard endpoint, KiSel-10 and Q-SYMBIO, used plain ubiquinone. Branded "high-absorption" cocrystal and liposomal products cite two- to four-fold gains in blood levels from small, industry-run studies, with no outcome data. The one robust rule is to take it with a meal that contains fat.[38]
Safety, and who should be careful
CoQ10 is well tolerated. Two industry-linked safety reviews put the observed safety level at 1,200 mg a day; stomach complaints were no more common at that dose than at 60 mg,[39] and supplementing does not suppress the body's own production.[40] Trouble sleeping and stomach upset are listed as occasional mild side effects.[41]
Warfarin: the evidence points both ways. CoQ10 is structurally similar to vitamin K, and a few case reports describe warfarin working less well after CoQ10 is started, with a falling international normalised ratio (INR), the standard measure of how "thin" the blood is.[42] An observational study of 171 warfarin users found those taking CoQ10 reported more bleeding episodes (self-reported, and not matched by over-thinned blood).[43] The one small randomized trial, at only 100 mg a day for four weeks, found no change in the warfarin dose needed.[44] No clinically important interaction is established with the newer direct oral anticoagulants.
Cancer treatment. In a study of about 1,100 women having chemotherapy for breast cancer, those who took antioxidant supplements (a group that included CoQ10) before and during treatment had about 40% higher risk of recurrence. The confidence interval just reached 1.0, so chance cannot be ruled out, and CoQ10 was not analysed on its own.[45]
The rules:
- On warfarin: don't start or stop CoQ10 without telling your prescriber and having your INR rechecked.
- Having cancer treatment: don't take CoQ10 or other antioxidant supplements without telling your oncologist.
- On blood-pressure or glucose-lowering drugs: CoQ10 can add modestly to them, worth knowing if you are near your target.
What to actually do
- If you are healthy, skip it. It is not in the same category as supplements with repletion or outcome evidence.
- If you have heart failure with reduced ejection fraction, or migraine, discuss it with your doctor; the trials used 300 mg a day — in heart failure, only as an add-on to standard treatment.
- For other reasons, 100–200 mg a day is enough. Primary CoQ10 deficiency is a specialist matter, treated at high doses.
- Buy plain ubiquinone and take it with a meal that contains fat. Timing is otherwise flexible; if sleep suffers, take it earlier in the day (practical advice, not a tested finding).
Further reading
- Alehagen U et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens (KiSel-10). Int J Cardiol 2013.[46]
- Mortensen SA et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure (Q-SYMBIO). JACC: Heart Failure 2014.[47]
- Al Saadi T et al. Coenzyme Q10 for heart failure. Cochrane Database of Systematic Reviews 2021.[48]
- Heidenreich PA et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation 2022.[49]
- Xu J et al. Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2024.[50]
- Liang L et al. Trends in Coenzyme Q10 Supplement Use and Associations With All-Cause and Cardiovascular Mortality: A Population-Based Cohort Study. Mol Nutr Food Res 2025.[51]
- Stürmer P et al. Higher Redox State of Coenzyme Q10 Is Associated with Higher Risk of All-Cause Mortality in a Sample from the Northern German General Population. Antioxidants 2026.[52]
- Montini G et al. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. New England Journal of Medicine 2008.[53]
- Sándor PS et al. Efficacy of coenzyme Q10 in migraine prophylaxis. Neurology 2005.[54]
- D'Adamo CR et al. A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations. J Nutr Metab 2026.[55]
- Nankivell MC et al. Coenzyme Q10 and Cognition: A Review. Nutrients 2025.[56]
- Hidaka T et al. Safety assessment of coenzyme Q10 (CoQ10). Biofactors 2008.[57]